Background Fibroblast growth factor-23 (FGF23) levels are elevated in cardiopulmonary bypass (CPB)-associated acute kidney injury (AKI); however, it is unknown how much of the circulating FGF23 is intact and bioactive. Hypoxia may induce FGF23 production, yet its impact in humans is unknown. Pediatric cardiac surgery patients have both a high incidence of CPB-associated AKI and a high prevalence of chronic hypoxemia. Methods We assessed the effects of hypoxemia and CPBassociated AKI on C-terminal FGF23 (cFGF23) and intact FGF23 (iFGF23) levels in 32 pediatric cardiac surgery patients with normal estimated glomerular filtration rate (eGFR). Plasma cFGF23 and iFGF23 were measured preoperatively and serially postoperatively. Results Despite normal renal and ventricular function, preoperative cFGF23 levels were high and elevated out of proportion to iFGF23 levels. Preoperative oxygen saturation measurements correlated inversely with FGF23 levels. Preoperative cFGF23 and oxygen saturation both predicted postoperative AKI. Postoperatively, cFGF23 and iFGF23 increased by 2 h postreperfusion; iFGF23 then returned to baseline, but cFGF23 remained elevated through 24 h postreperfusion.
Introduction
Fibroblast growth factor 23 (FGF23) is secreted by osteocytes; it induces phosphaturia and decreases renal 1α-hydroxylase expression [1] , physiologically functioning as a homeostatic regulator of phosphate and as a calcitriol counterregulatory hormone. In the setting of chronic kidney disease (CKD), circulating FGF23 levels increase as renal function declines [2, 3] and are associated with progressive kidney disease [4, 5] and increased cardiovascular morbidity and mortality [5, 6] .
Although FGF23 has been studied extensively in CKD, much less is known about FGF23 in the context of acute kidney injury (AKI). In a murine model of AKI, circulating FGF23 levels increased as early as 1 h after AKI induction, and did so independently of phosphate, calcitriol, and parathyroid hormone (PTH) [7] . Studies in humans with AKI have demonstrated that FGF23 concentrations, determined by the C-terminal assay, are increased in both adult [7] [8] [9] and pediatric [10] patients and that these elevated levels are associated with poor clinical outcomes [8, 9] . However, it is unknown whether the high FGF23 levels in AKI reflect the intact bioactive molecule or C-terminal fragments.
Not only are FGF23 levels increased in the setting of AKI, but in a small case-control study of pediatric cardiac surgery patients, Ali et al. demonstrated that those patients who developed postoperative AKI had higher preoperative FGF23 levels [10] . The etiology of these elevated preoperative levels is unclear, but subclinical kidney dysfunction [10] or poor cardiac function [11] may have been contributory. Yet, other factors may also promote FGF23 production. Hypoxia has been shown to induce FGF23 expression in osteoblast-like cell lines [12, 13] and increase circulating FGF23 levels in rats [13] ; however, its impact in humans is unknown.
In this study, we aimed to: (i) determine whether or not chronic hypoxemia is associated with FGF23 levels in humans; (ii) assess the ability of preoperative FGF23 levels to predict postoperative AKI; and (iii) determine how measurements of C-terminal and intact FGF23 (iFGF23) are affected by AKI. The study population comprised pediatric patients undergoing cardiopulmonary bypass (CPB), which is a population well-suited for our study, as cyanotic (hypoxemic) congenital heart disease is not uncommon in the pediatric cardiology population [14] , and there is a high incidence of CPB-associated AKI after surgical correction [15] .
Methods

Study participants
Study participants were recruited from the UCLA Pediatric Cardiothoracic Surgery program. Patients aged 0-18 years scheduled to undergo cardiac surgery requiring CPB were eligible. An additional inclusion criterion was an estimated glomerular filtration rate (eGFR) of ≥60 ml/min/1.73 m 2 at the time of surgery. Outpatients were enrolled at their preoperative clinic visits, which for almost all occurred within 6 days of their operative dates, and inpatients were enrolled from the wards within 2 days prior to surgery.
Following inclusion, demographic data were obtained from the medical records. Preoperative oxygen saturation measurements via pulse oximetry were recorded from preoperative clinic visit, anesthesia, or inpatient notes. In order to verify stable oxygen saturations over time, we also recorded oxygen saturations documented at least 1 week-and preferably 1 month-preoperatively and compared these remote measurements to preoperative values.
Study procedures
Plasma and serum were collected preoperatively and at 2, 6, 12, 24, and 48 h postreperfusion. For outpatients, preoperative blood was collected on the day of the preoperative clinic visit, which occurred at a median of 3 (1-4) days prior to surgery.
For inpatients, preoperative blood was collected 1-2 days prior to the operative date. Samples were placed on ice, centrifuged, aliquoted, and stored at −80°C. Preoperative and postoperative plasma C-terminal and iFGF23 levels were measured in duplicate using standard ensyme-linked immunosorbent assay (ELISA) kits (Immutopics, San Clemente, CA, USA). Preoperative and postoperative serum parathyroid hormone (PTH) was assayed using a second-generation assay (Immutopics). Preoperative plasma B-type natriuretic peptide (BNP) was measured using the Triage® Kit (Alere, Waltham, MA, USA).
As part of routine preoperative care, serum creatinine, phosphate, and calcium were measured. Postoperatively, in the Cardiothoracic Intensive Care Unit, they were measured daily. AKI was defined as an increase in serum creatinine of at least 50 % from preoperative levels, as established by the Acute Kidney Injury Network [16] , occurring within 48 h of surgery. A large study of pediatric cardiac surgery patients demonstrated that most patients who develop AKI, defined as a 50 % increase in creatinine, did so within 24 h of surgery, and almost all did so within 48 h of surgery [15] . As our serum creatinine measurements were determined by the alkaline picrate method (Jaffe method), eGFR was calculated by the original Schwartz equation [17, 18] . All preoperative echocardiograms were interpreted by the same pediatric cardiologist.
Statistical analysis
Data are reported as means and standard errors of the means (SEM) or medians and interquartile ranges (IQR), as was suitable for data distributions. Continuous or ordinal preoperative variables were compared between AKI and non-AKI groups using Student's t test or the Mann-Whitney U test, according to data distributions. Categorical variables between groups were compared using Fisher's exact test. Comparisons were two-tailed, with p<0.05 considered significant. Correlations between preoperative oxygen saturations and FGF23 levels were analyzed using Pearson product-moment correlation coefficients.
C-terminal FGF23 (cFGF23) levels vary physiologically with age in the pediatric population, decreasing from a median value of 105 (75-153) RU/ml in infants to 60-80 RU/ml in children and adolescents [19] . To adjust for age, we calculated preoperative age-related cFGF23 standard deviation scores (SDS) using cFGF23 data obtained from a large, age-specific cohort of healthy children, determined by the Immutopics assay, as described by Fischer et al. [19] . The SDS, also known as a z-score, is defined as the number of standard deviations an observation is above the mean. Phosphate levels also vary with age, and published data was used to calculate preoperative age-adjusted phosphate SDS [20] . As age-adjusted normal values do not exist for iFGF23, the absolute value of this parameter was used in all analyses. For comparison, we also measured iFGF23 and cFGF23 levels, using the same Immutopics assays, in an institutional cohort of 47 healthy children.
Potential preoperative predictors of postoperative kidney dysfunction were assessed for two outcomes: AKI vs. no AKI (dichotomous outcome), and maximum percent decrease in eGFR (continuous outcome). Receiver operating characteristic (ROC) curve analysis and multiple logistic regression modeling were used to assess the ability of preoperative factors to predict postoperative CPB-associated AKI. Multiple linear regression modeling was used to assess the ability of preoperative factors to predict postoperative percent decrease in eGFR. Regression models included FGF23 values or oxygen saturation, age, and CPB time; age and CPB time are known risk factors for CPB-associated AKI [15] .
Linear mixed effects modeling was used to examine changes in FGF23 levels over time and the effects of group (AKI vs. no AKI) on FGF23 levels. Both cFGF23 and iFGF23 values were log-transformed prior to modeling. The models included terms for time, group, and group-by-time interaction. To assess the effects on FGF23 levels through different time points, different models were created, sequentially truncating the data set by removing the last time point. As such, the full model included all data through the 48-h time point, the first truncated model included all data through the 24-h time point, the second truncated model included all data through the 12-h time point, etc. Linear mixed-effects modeling was also used to assess changes in phosphate, calcium, and PTH over time.
All statistical analysis was performed using SigmaPlot 11.0 (San Jose, CA, USA) software, with the exception of linear mixed-effects modeling, which was performed using SAS (Cary, NC, USA) software.
Results
Preoperative patient characteristics Table 1 shows preoperative characteristics of the 32 study patients. Median age was 37 (10-80) months, and mean eGFR was 141±42 ml/min/1.73 m Ventricular function, assessed qualitatively by echocardiogram, was normal in 29 patients (91 %); three patients had mildly depressed function. The surgical procedures performed are listed in Table 2 . Postoperatively, 20 patients (62.5 %) developed at least stage 1 AKI according to the Acute Kidney Injury Network (AKIN) criteria [16] . The AKI group was younger than the no AKI group and thus had lower preoperative creatinine; however, preoperative eGFR did not differ between groups. Preoperative cFGF23 levels and age-adjusted cFGF23 SDS were higher in the AKI group; however, iFGF23 levels did not differ between groups. Preoperative oxygen saturation (SpO 2 ) was lower in the AKI group (Table 1) . Of the 15 patients with preoperative SpO 2 <95 %, cardiac surgery improved saturations in all patients and normalized saturations in ten.
Postoperative renal function
Peak postoperative percent change in serum creatinine was 74 (67-100) % in the AKI group and 21 (0-25) % in the no AKI group (p<0.001). All AKI developed within 24 h of surgery, with the exceptions of two patients who were diagnosed at 26 h and 39 h postreperfusion. A large prospective study of pediatric cardiac surgery patients observed a similar early development of CPB-associated AKI [15] . Percent change in creatinine over time is shown in Fig. 1a .Serum creatinine levels returned to baseline by postoperative day 5 in all patients. No patient became oliguric postoperatively or required renal replacement therapy.
Postoperative changes in cFGF23 levels
For all patients, median peak cFGF23 level was 1629 (596-5085) RU/ml, with a median 6 (2-18) fold change; levels increased early and markedly postreperfusion (Fig. 1b) . Linear mixed-effects modeling revealed that levels were higher than preoperative values by 2 h postreperfusion (p<0.001) and remained higher through 24 h postreperfusion (p<0.001). However, there was no evidence of an interaction between group and time, such that group status did not modify the effect of time on cFGF23 levels.
Postoperative changes in iFGF23 levels
For all patients, the median peak iFGF23 level was 84 (62-152) pg/ml, with a median 1.7 (1.2-2.6) fold change. Like cFGF23 levels, iFGF23 levels increased in the early postoperative period; however, unlike cFGF23 levels, they returned to baseline soon thereafter (Fig. 1c ). They were also higher than preoperative values at 2 h postreperfusion (p<0.001) but not at subsequent time points. In fact, at the 48 h time point, they were lower than preoperative values (p<0.001). At the 2 h time point, there was an interaction between group and time, such that levels increased to a greater degree in the AKI group than in the no AKI group (p=0.04). There was no interaction detected at the 48 h time point.
Postoperative changes in phosphate, calcium, and PTH levels Postoperative serum phosphate concentrations peaked at an average of 13 h postreperfusion, increasing by 21±8 % in the AKI group and 2±9 % in the no AKI group (p=0.12). Serum phosphate then decreased to levels significantly lower than preoperative values (p<0.001, Fig. 1d) . By an average of 13 h postreperfusion, serum calcium levels decreased to below preoperative levels, with a nadir decrease of 10±2 % in the AKI group and 7±2 % in the no AKI group (p=0.21); they then remained significantly lower than preoperative values (p<0.001, Fig. 1e ). PTH levels increased over time to a greater degree in the AKI group than in the no AKI group (p=0.04, Fig. 1f ).
Preoperative FGF23 as a predictor of CPB-associated AKI Preoperative cFGF23 SDS predicted postoperative CPBassociated AKI (Fig. 2) . In multiple logistic regression ]. Yet, given the loss of power inherent to outcome dichotomization (AKI vs. no AKI), and given that decrements in kidney function of <50 % (not meeting the AKI threshold) may still be relevant, we also assessed a continuous outcome variable; the percent decrease in eGFR. Multiple linear regression modeling revealed that after adjusting for age and CPB time, preoperative cFGF23 SDS was positively associated with postoperative percent decrease in eGFR (B=3.5; 95 % CI 1.0-6.0), p=0.008). All three covariates were significantly associated with the outcome. The addition of cFGF23 SDS as a covariate to a model that already included age and CPB time increased the adjusted R 2 from 0.46 to 0.57, indicating a relatively large increase in the degree to which the covariates explain variability in the outcome measure. Using cFGF23 SDS as a covariate, as opposed to cFGF23 levels, allowed us to assess the ageindependent effects of cFGF23 and avoid the collinearity that arose when including cFGF23 levels with age. After adjustment for age and CPB time, iFGF23 levels were not associated with postoperative percent decrease in eGFR (p=0.33). Fig. 1 a Percent change in serum creatinine over time. The dotted line represents the acute kidney injury (AKI) threshold (50 % increase in creatinine from baseline). b C-terminal fibroblast growth factor 23 (cFGF23) levels over time. Linear mixed-effects modeling showed that cFGF23 levels were significantly higher than preoperative values by 2 h postreperfusion and through 24 h postreperfusion. Group status did not modify the effect of time on cFGF23 levels. c Intact FGF23 (iFGF23) levels over time. Linear mixed-effects modeling showed that iFGF23 levels were significantly higher than preoperative values at 2 h postreperfusion but not at subsequent time points. Group status modified the effect of time on iFGF23 levels at the 2-h time point. d Serum phosphate levels over time. Levels peaked~13 h postreperfusion, then decreased to below preoperative values. e Serum calcium levels over time. By 13-h postreperfusion, serum calcium levels decreased to below preoperative values. f Serum parathyroid hormone (PTH) levels over time. Levels increased over time to a greater extent in the AKI group. All data are presented as means and standard error of the mean (SEM)
Association of preoperative oxygen saturation and FGF23 levels
SpO 2 inversely correlated with cFGF23 SDS (r=− 0.65, p<0.001, Fig. 3 ), cFGF23 levels (r=−0.48, p=0.005), and iFGF23 levels (r=− 0.35, p=0.047). Previous SpO 2 values measured at a median of 37 (24-54) days prior to preoperative SpO 2 determinations were highly correlated with preoperative measurements (r=0.96, p<0.001), suggesting measurement stability over time. In multiple linear regression modeling, preoperative SpO 2 remained negatively associated with cFGF23 SDS, independent of serum phosphate SDS (SpO 2 p<0.001) or phosphate SDS (SpO 2 p=0.002).
As chronic hypoxemia may adversely affect kidney function [22] [23] [24] , potentially rendering the kidney less tolerant to CPB, we hypothesized that preoperative SpO 2 may also predict postoperative CPB-associated AKI. Like cFGF23 SDS, preoperative SpO 2 predicted postoperative CPB-associated AKI (Fig. 2) . In regression analyses, given its high correlation with cFGF23 SDS, preoperative SpO 2 was not included as a predictor covariate in our original models. However, after excluding cFGF23 SDS from the models and adjusting for age and CPB time, preoperative SpO 2 was negatively associated with AKI in logistic regression (OR=0.83; 95 % CI 0.71-0.98; p=0.03), and negatively associated with postoperative percent decrease in eGFR in linear regression (B=−0.5; 95 % CI −1.0 to −0.02); p=0.04). The addition of SpO 2 as a covariate to a linear regression model that already included age and CPB time increased the adjusted R 2 from 0.46 to 0.52.
Discussion
Results of this study confirm previous observations demonstrating elevated cFGF23 levels in AKI patients [7] [8] [9] [10] , as well as the ability of cFGF23 to predict the development of AKI [10] , as defined by an increase in serum creatinine of at least 50 % from baseline. However, we also present the novel finding that in patients with cardiopulmonary-bypassassociated acute kidney dysfunction, cFGF23 levels remain elevated for a longer duration than do iFGF23 levels. Furthermore, in pediatric congenital-heart-disease patients, chronic hypoxemia is associated with elevated FGF23 levels. In the setting of acute kidney dysfunction, there is an early and marked elevation in cFGF23 levels, as previously described in a murine AKI model [7] . C-terminal levels increased considerably in our AKI group and even increased five fold in the no AKI group, in whom there was only a 21 % median peak increase in creatinine levels. The increase of cFGF23 levels in the no AKI group may be attributable to subclinical kidney dysfunction or to an inflammatory response. The observation that cFGF23 levels increased out of proportion to the degree of acute kidney dysfunction has been previously observed and ascribed-at least in part-to a systemic inflammatory response to surgery [7] . Indeed, in CKD patients, higher cFGF23 levels are independently associated Fig. 2 Receiver operating characteristic (ROC) curves for acute kidney injury (AKI) prediction. The C statistic represents the area under the ROC curve. The C statistic ranges from 0.5, which is denoted by the diagonal line and corresponds to no predictive ability, to 1.0, which represents perfect predictive ability. Individually, age, preoperative oxygen saturation, and preoperative C-terminal FGF23 (cFGF23) age-adjusted standard deviation scores (SDS) predicted postoperative cardiopulmonary bypass (CPB)-associated AKI Fig. 3 Relationship between preoperative C-terminal fibroblast growth factor 23 (cFGF23) standard deviation scores (SDS) and oxygen saturation. Preoperative oxygen saturation correlated negatively with preoperative cFGF23 age-adjusted SDS. Also, whereas 13/15 (87 %) patients with oxygen saturation <95 % developed acute kidney injury (AKI), only 7/17 (41 %) with oxygen saturation ≥95 % developed AKI (p=0.01) with elevated markers of inflammation [25] . Proposed mechanisms by which circulating FGF23 levels may increase in AKI include increased production from bone; increased ectopic production, possibly from damaged renal tubules; decreased renal clearance; decreased degradation; and/or release of stored, preformed hormone [7, 26] . Although hyperphosphatemia may represent a stimulus for FGF23, FGF23 levels increased before phosphate concentrations peaked. Furthermore, in the no AKI group, FGF23 levels increased by 2 h postreperfusion despite a slight decrease in serum phosphate.
Although FGF23 is nearly all intact and biologically active in patients with end-stage kidney disease [27] , the correlation between measurements made by the C-terminal and intact FGF23 assays is not as strong in individuals with preserved kidney function [28] . We measured FGF23 levels using both the C-terminal and intact assays. Our study sample had a median preoperative cFGF23 level of 295 (range 59-2653) RU/ ml and a median iFGF23 level of 56 (range 27-129) pg/ml. As cFGF23 levels vary with age, we used preoperative ageadjusted SDS in our analyses, calculated as detailed in Fischer et al. [19] . Although cFGF23 levels were clearly elevated for age (mean age-adjusted SDS of 2.28) [19] , similar ageadjusted normal values do not exist for iFGF23. However, the iFGF23 values were similar to those observed in our institutional cohort of 47 healthy children (mean age 11.3 years). Although this cohort was older than our study sample, given that serum phosphate levels are higher in younger children, it seems unlikely that normal iFGF23 levels in younger children would be so much lower as to suggest that our observed preoperative iFGF23 values were dramatically elevated. Indeed, in our healthy cohort, iFGF23 tended to correlate negatively with age (r=−0.28, p=0.06); similarly, cFGF23 levels tended to be higher, not lower, in younger children [19] . Therefore, the study sample had unexpectedly high preoperative cFGF23 levels that were elevated out of proportion to iFGF23 levels. These observations suggest that although preoperative FGF23 production may have been increased, proteolytic cleavage mechanisms [29] may have been concurrently upregulated, maintaining levels of iFGF23 that are closer to the normal range, similar to what is thought to occur in the setting of iron deficiency [30] [31] [32] .
Postoperatively, both cFGF23 and iFGF23 levels increased by 2 h postreperfusion; however, cFGF23 remained elevated for a longer duration than iFGF23 levels. This discrepancy suggests that different factors may affect FGF23 transcription and posttranslational cleavage. Group status modified the effect of time on changes in iFGF23 levels but not cFGF23 levels, suggesting that overall FGF23 transcription, of which cFGF23 levels may be considered a surrogate measure, was affected less by decreased GFR and more by other factors, such as inflammation. Moreover, the generally similar trends in FGF23 levels over time between the AKI and no AKI groups suggest that factors besides kidney function affected circulating FGF23 concentrations. At 12 h postreperfusion, a relative decrease in iFGF23 levels was observed, the etiology of which is unclear. In the AKI group, this decrease occurred in the setting of phosphate levels that were increased from baseline; in the no AKI group, this decrease occurred in the setting of phosphate levels that were similar to baseline. These observations suggest that other factors besides serum phosphate affected iFGF23 levels, as previously suggested by Christov et al. [7] .
Interestingly, preoperative phosphate concentrations were relatively low for age (mean age-adjusted phosphate SDS of −1.49). Given that preoperative iFGF23 values were similar to those observed in the cohort of healthy children, it seems u n l i k e l y t h a t i F G F 2 3 w a s c a u s i n g t h e r e l a t i v e hypophosphatemia. The effects of PTH and 1,25(OH) 2 vitamin D may have played a role. However, relative malnutrition may have been more contributory, as evidenced by the cohort's below-average growth parameters (mean age-adjusted weight SDS of −1.49; mean age-adjusted height SDS of −1.22). Phosphate values decreased to below preoperative levels by 37 h postreperfusion. It is unlikely that this postoperative relative hypophosphatemia was entirely caused by elevated iFGF23 levels, which peaked at 2 h postreperfusion. Nutritional status may have been contributory, as many patients in the early postoperative period remained on intravenous fluids and had yet to be advanced to full enteral feeds or parenteral nutrition. It is possible that the elevated PTH levels, a t l e a s t i n th e A K I g r o u p , a l s o c o n t r i b u t e d t o hypophosphatemia. Decreased 1,25(OH) 2 vitamin D levels may also have contributed, although in the setting of nearly recovered renal function, lower iFGF23 levels and higher PTH levels would be expected to increase 1,25(OH) 2 vitamin D production. However, the relative hypophosphatemia may have contributed to the decrease in iFGF23 levels to below baseline at 48 h postreperfusion.
Similar to a previous study of FGF23 levels in the pediatric CPB population [10] , we observed that preoperative cFGF23 levels and SDS were markedly higher in patients who went on to develop AKI. It is unclear why higher preoperative FGF23 levels are associated with worse postoperative renal function; it is unknown whether higher levels have some direct pathologic effect promoting renal injury, or if FGF23 represents a surrogate marker for another factor that is associated with worse postoperative renal function. It has been hypothesized that subclinical kidney dysfunction may contribute to both high preoperative FGF23 levels and postoperative CPBassociated AKI [10] . Cardiac status may also be contributory. In a study of pediatric heart failure patients with normal mean eGFR, FGF23 levels were elevated compared with controls and correlated with heart failure severity [11] . As such, high preoperative FGF23 levels and postoperative kidney dysfunction may, in part, be attributable to poor cardiac function.
However, our study sample did not have heart failure, as evidenced by low serum BNP values-which is a sensitive marker of heart failure [33, 34] -and qualitatively normal ventricular function on echocardiogram.
An interesting observation from this study is the potential role of hypoxemia in the association between high preoperative cFGF23 levels and postoperative kidney dysfunction. Preoperative cFGF23 levels and oxygen saturation negatively correlated, and both variables predicted kidney dysfunction, suggesting that elevated cFGF23 levels possibly represented a surrogate marker for hypoxemia. Chronic hypoxia affects renal cellular function [22] [23] [24] , and small studies of pediatric patients with cyanotic congenital heart disease demonstrated evidence of tubular and glomerular damage [35] [36] [37] . As such, some degree of cyanotic nephropathy-associated renal compromise may have rendered the kidneys of our hypoxemic patients less tolerant to CPB and possibly more susceptible to AKI. The associations between hypoxemia and FGF23 levels in humans have not been previously described; however, increased FGF23 expression has been observed in osteoblast-like cell lines under hypoxic conditions [12, 13] , and elevated circulating levels have been observed in hypoxic rats [13] . Compared with controls, hypoxic rats had much higher cFGF23 levels but comparable iFGF23 levels [13] . In the study reported here, SpO 2 negatively correlated with FGF23 levels, suggesting an association between chronic hypoxemia and increased FGF23 production.
Limitations of our study include the small sample size, the relatively short duration of postoperative measurement, incomplete biochemical assessment [including lack of 1, 25(OH) 2 vitamin D levels and inflammatory markers], and the observational nature of our findings. Furthermore, this study sample developed only mild AKI; therefore, changes in iFGF23 may be underestimated given the lesser degree of renal dysfunction.
In summary, although elevated FGF23 levels have been previously described in CPB-associated AKI, the findings we report here provide new insights into how AKI may affect FGF23 levels. In mild AKI, cFGF23 levels are increased for a longer duration than iFGF23 levels, possibly suggesting alterations in cleavage mechanisms. Preoperatively, age-adjusted cFGF23 SDS may predict CPB-associated kidney dysfunction. Furthermore, for the first time in humans, we identified an association between chronic hypoxemia and FGF23 levels. Further studies will be needed to elucidate the mechanisms by which hypoxemia and acute kidney dysfunction may result in elevated FGF23 levels.
